Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03090230 · ClinicalTrials.gov registry record · NA
Study of the Relay Pro® Thoracic Stent-Graft in Subjects With Traumatic Injury of the Descending Thoracic Aorta
A NA study of Other Specified Injury of Thoracic Aorta, sponsored by Bolton Medical.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 16
- Study locations
NCT03090230 is a NA study of Other Specified Injury of Thoracic Aorta that is active but no longer recruiting, run by Bolton Medical. The registered enrollment target is 50 participants. The trial reports 16 study locations across 15 states.
The verdict
NCT03090230, a NA study of Other Specified Injury of Thoracic Aorta, is active but no longer recruiting, sponsored by Bolton Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 16
- Study locations
Study Summary
The purpose of this study is to investigate the safety and effectiveness of the RelayPro Thoracic Stent-Grafts in subjects with traumatic injury of the descending thoracic aorta (DTA)
Conditions Studied
Interventions
- DEVICE Relay Pro Thoracic Stent-Graft System
Study Locations (16)
California
- University of California, Irvine - Irvine
- Stanford Medicine - Stanford
Connecticut
- Yale School of Medicine - New Haven
Georgia
- Grady Memorial Hospital - Atlanta
Indiana
- Indiana University Health - Indianapolis
Iowa
- University of Iowa Hospital and Clinic - Iowa City
Maryland
- University of Maryland Medical Center - Baltimore
Massachusetts
- Beth Israel Deaconess Medical Center / Harvard Medical School - Boston
Missouri
- St. Louis University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2017-04-17 |
| Est. Completion | 2025-11-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03090230
The ClinicalTrials.gov registry entry for NCT03090230 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bolton Medical, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Other Specified Injury of Thoracic Aorta appearing as the primary indexed condition, and to 1 intervention - of which Relay Pro Thoracic Stent-Graft System is the first listed.
NCT03090230 reports 16 study locations spanning 15 distinct geographic areas - top geographies include California, Connecticut, Georgia.
Frequently Asked Questions
What is clinical trial NCT03090230 about?
NCT03090230 is a clinical study titled "Study of the Relay Pro® Thoracic Stent-Graft in Subjects With Traumatic Injury of the Descending Thoracic Aorta". The purpose of this study is to investigate the safety and effectiveness of the RelayPro Thoracic Stent-Grafts in subjects with traumatic injury of the descending thoracic aorta (DTA)
What is the current status of trial NCT03090230?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2017-04-17. Estimated completion is 2025-11-22.
What conditions does trial NCT03090230 study?
This clinical trial studies the following conditions: Other Specified Injury of Thoracic Aorta.
What interventions are being tested in trial NCT03090230?
The interventions under investigation include: Relay Pro Thoracic Stent-Graft System (DEVICE).
Who is sponsoring clinical trial NCT03090230?
This trial is sponsored by Bolton Medical, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03090230 being conducted?
This trial has 16 study locations across California, Connecticut, Georgia, Indiana, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.